Clinical trial
Study B2C111045, A Dose-Finding Study of GW642444 Versus Placebo in Patients With COPD
NCT00606684 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study B2C111045, A Dose-Finding Study of GW642444 Versus Placebo in Patients With COPD
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- October 31, 2008
- Enrollment
- 602 (actual)
- Sites
- 99
Conditions
As the registry lists them; a condition with its own page is linked.